Pfizer and the Hokkaido prefectural government have signed a comprehensive partnership agreement, which encompasses a broad range of collaborations including for raising awareness on measures to combat tick-borne encephalitis (TBE). The two parties concluded the agreement on November 20, they…
To read the full story
Related Article
- Japan’s 1st Tick-Borne Encephalitis Vaccine Now Available: Pfizer
September 17, 2024
BUSINESS
- Teikoku to Market Medipost’s Knee OA Cell Therapy in Japan
December 22, 2025
- Clinigen Japan Adds 4 Products, Including Takeda’s Buccolam
December 22, 2025
- Meiji Backs US Incubator MBC BioLabs to Boost Open Innovation
December 22, 2025
- Boehringer Passes on Option for Nxera’s Schizophrenia Program
December 22, 2025
- Otsuka Kicks Off Global PIII of Phenylketonuria Drug
December 22, 2025
Let’s be real: even with the best intentions, AI systems can reflect our own unconscious biases. As Daniel Kahneman and Amos Tversky famously demonstrated in their groundbreaking work on Prospect Theory, humans are prone to cognitive biases that influence our…





